User profiles for C. Finke

Carsten Finke

Heisenberg Professor and Consultant Neurologist, Dept. of Neurology, Charité …
Verified email at charite.de
Cited by 6237

Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis

…, R Diem, A Daly, H Dollfus, C Fasser, C Finke… - The Lancet …, 2017 - thelancet.com
Background Structural retinal imaging biomarkers are important for early recognition and
monitoring of inflammation and neurodegeneration in multiple sclerosis. With the introduction …

Imaging of autoimmune encephalitis–Relevance for clinical practice and hippocampal function

J Heine, H Prüss, T Bartsch, CJ Ploner, F Paul, C Finke - Neuroscience, 2015 - Elsevier
The field of autoimmune encephalitides associated with antibodies targeting cell-surface
antigens is rapidly expanding and new antibodies are discovered frequently. Typical clinical …

Combined physical and cognitive training for older adults with and without cognitive impairment: A systematic review and network meta-analysis of randomized …

…, ML Mellow, AT Wade, AE Smith, C Finke… - Ageing research …, 2021 - Elsevier
Combining physical exercise with cognitive training is a popular intervention in dementia
prevention trials and guidelines. However, it remains unclear what combination strategies are …

Mutations and prognosis in primary myelofibrosis

…, A Pereira, C Finke, J Score, N Gangat, C Mannarelli… - Leukemia, 2013 - nature.com
Patient outcome in primary myelofibrosis (PMF) is significantly influenced by karyotype. We
studied 879 PMF patients to determine the individual and combinatorial prognostic relevance …

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

…, P Guglielmelli, DR Larson, C Finke… - Blood, The Journal …, 2014 - ashpublications.org
Janus kinase 2 (JAK2) mutations define polycythemia vera (PV). Calreticulin (CALR) and
myeloproliferative leukemia virus oncogene (MPL) mutations are specific to JAK2-unmutated …

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

A Tefferi, TL Lasho, CM Finke, RA Knudson… - Leukemia, 2014 - nature.com
… of an initial denaturation at 94 C for 2 min; 40 cycles of denaturation at 94 C for 15 s, annealing
at 56 C for 30 s, and extension at 72 C for 45 s; and final extension at 72 C for 1 min. PCR …

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

KH Lim, A Tefferi, TL Lasho, C Finke… - Blood, The Journal …, 2009 - ashpublications.org
… BM aspirates and trephine sections were reviewed by one of us (C.-YL). All patients … ;
identified by § in Table 5) represent B- or C-findings and are therefore already accounted for in the …

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

…, TL Lasho, J Patel, N Gangat, CM Finke… - Leukemia, 2009 - nature.com
High-throughput DNA sequence analysis was used to screen for TET2 mutations in bone
marrow-derived DNA from 239 patients with BCR-ABL-negative myeloproliferative neoplasms (…

N‐methyl‐D‐aspartate receptor antibodies in herpes simplex encephalitis

…, C Finke, M Höltje, J Hofmann, C Klingbeil… - Annals of …, 2012 - Wiley Online Library
… (C) No staining is observed of transfected cells probed with IgM-positive serum, but an
anti-IgG secondary antibody. (D–F) Higher magnification of NR1-transfected cells demonstrating …

Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera

A Pardanani, TL Lasho, C Finke, CA Hanson, A Tefferi - Leukemia, 2007 - nature.com
… o C, followed by 35 cycles of 30 s at 94 o C, 45 s at 58 o C, and 45 s at 72 o C, followed by a
final step of 1 min at 72 o C… o C, followed by 35 cycles of 10 s at 94 o C, 45 s at 60 o C (0.2 o …